Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The Trust Test

- PMLiVE

A creative awakening – how pharma is bringing innovation to the patient journey

By Danny Buckland

Top 10 Benefits of Virtual Advisory Boards

As the world is slowly starting to open up again, it can be tempting to rush back to the pre-pandemic days of in-person advisory boards. However, it would be foolish...

Impetus Digital

- PMLiVE

MEDSCAPE EDUCATION: The Human Story in Virtual Patient Simulation

WHAT'S THE STORYStories are shared experiences, where meaning-centered approaches and coping strategies ascribe cultural meaningto events and emotions; a way to merge the individual and the collective experience into the...

Medscape Education

dengue fever mosquito

Novartis endorses Kigali Declaration by investing $250m for tropical diseases

1.7 billion people suffer from neglected tropical diseases worldwide, and there are 241 million cases of malaria

- PMLiVE

Moderna to launch Innovation and Technology Center in the UK

With support from the UK government, the manufacturing facility is expected to produce up to 250 million doses annually

- PMLiVE

Biogen and Happify Health team up to create digital platform for MS patients

There are over 2.3 million people living with MS worldwide, with women being more likely to develop the condition than men

- PMLiVE

ALL SYSTEMS GO: UNDERSTANDING WHO’S WHO IN THE NEW NHS LANDSCAPE

With the Health and Care Act safely passed, Oli Hudson introduces six key stakeholders that will loom large in the new landscape.

Wilmington Healthcare

- PMLiVE

Windrush Day

Innnovative Trials' Equality & Diversity committee raises awareness around Windrush Day and the Windrush generation

Innovative Trials

Seven Stones Collective Agency Reel

SEVEN STONES COLLECTIVE

- PMLiVE

Novo Nordisk and Echosens collaborate to advance early diagnosis of non-alcoholic steatohepatitis

The companies aim to double diagnostic rates for those with advanced to severe forms of the disease by 2025

- PMLiVE

Pfizer to buy 8.1% stake in Valneva in support of joint Lyme disease programme

VLA15 is the only Lyme disease vaccine candidate currently in clinical development

- PMLiVE

University of Strathclyde develops pre-clinical screening tool which could increase cancer test numbers by up to 50 times

The study utilises 3D models that provide more accurate data than the 2D models that are currently used

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links